Secretome Therapeutics, based in Dallas, Texas, is developing innovative therapies from neonatal cardiac progenitor cells to treat cardiovascular diseases and other underserved diseases driven by inflammation.
We're building DxMultiomics to be The Central Nexus of Biotech Intelligence. To ensure a seamless experience and continuous improvement, we utilize website analytics. These tools help us monitor site performance, understand how users navigate the platform, and identify opportunities to make your research journey more efficient. We handle this data with the utmost respect for your privacy, and you can choose what works best for you.